BioHealth News Archive

Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight

Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight

Twenty-four week interim analysis on approximately 160 subjects planned for Q1 2023 September 28, 2022 07:30 ET | Source: Altimmune, Inc GAITHERSBURG, Md., Sept. 28, 2022…

Read More
Emmes Acquires Clinical Edge

Emmes Acquires Clinical Edge

The Company's Fifth Acquisition Deepens Ophthalmology Credentials and Enhances Global Reach ROCKVILLE, Md., Sept. 28, 2022 /PRNewswire/ -- Emmes, a global, full-service Clinical Research…

Read More
Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

GAITHERSBURG, Md., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of exclusive worldwide…

Read More
President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H) – The White House

President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H) – The White House

Today, President Joe Biden announced his intent to appoint Dr. Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health…

Read More
Neuroene Therapeutics Wins 7th Annual BioHealth Capital Region Crab Trap Competition

Neuroene Therapeutics Wins 7th Annual BioHealth Capital Region Crab Trap Competition

ROCKVILLE, MARYLAND, September 26, 2022 – When it was announced that the winner of the 7th Annual BioHealth Capital Region Crab Trap would be the recipients…

Read More
BioBuzz: Neuroene Therapeutics Wins 7th Annual Crab Trap Competition

BioBuzz: Neuroene Therapeutics Wins 7th Annual Crab Trap Competition

Gaithersburg-based Neuroene Therapeutics and its approach to treating a rare form of epilepsy were crowned the winner of the seventh annual Crab Trap Competition, which…

Read More
Sarah Miller with BHI – Excited to be a panelist for this timely discussion.

Sarah Miller with BHI – Excited to be a panelist for this timely discussion.

BaneBio is proud to be a sponsor of this invite-only VIP panel event I-270 Innovation Labs.   {iframe}https://www.linkedin.com/posts/douglasbane_banebio-biohealth-activity-6979963173449691136-aJ5W/?utm_source=share&utm_medium=member_ios{/iframe}

Read More
Game changers: Regional effort links academics and entrepreneurs with economic development

Game changers: Regional effort links academics and entrepreneurs with economic development

Startups. Capital. Entrepreneurship. These weren’t always terms in Amy White’s daily lexicon. A trained scientist, White dedicated 15 years to teaching microbiology, focusing on…

Read More
Emergent BioSolutions inks deal for smallpox newcomer Tembexa

Emergent BioSolutions inks deal for smallpox newcomer Tembexa

Emergent BioSolutions, already flush with products against public health threats like anthrax attacks and opioid overdoses, is expanding its arsenal of medical countermeasures by…

Read More
Senate pulls SBIR back from brink of sunsetting | Federal News Network

Senate pulls SBIR back from brink of sunsetting | Federal News Network

The Small Business Innovation Research program is a big step further away from ending. The Senate passed a three-year authorization of SBIR and the…

Read More
HemoShear Therapeutics Advancing Novel Modulators Against Second Target for Horizon Therapeutics’ Gout Discovery Pipeline

HemoShear Therapeutics Advancing Novel Modulators Against Second Target for Horizon Therapeutics’ Gout Discovery Pipeline

Fifth Milestone Achieved by HemoShear with Novel Compounds for Second Target CHARLOTTESVILLE, Va., Sept. 21, 2022 /PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held clinical stage…

Read More
University of Maryland, Baltimore and Wexford Meeting Critical Demand for Wet Lab Space in Baltimore Region | UM BioPark

University of Maryland, Baltimore and Wexford Meeting Critical Demand for Wet Lab Space in Baltimore Region | UM BioPark

Doubling the University of Maryland BioPark's lab space, the two-phase 4MLK development project will represent more than $320 million in total capital investment BALTIMORE,…

Read More
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor

MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor

ROCKVILLE, Md., Sept. 21, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies…

Read More

White House Unveils Strategy To Grow Trillion Dollar U.S. Bioeconomy

The U.S. bioeconomy is booming. Valued at nearly one trillion dollars and predicted to grow globally to over $30 trillion over the next two…

Read More
UCSF scientist says Biden’s cancer moonshot achievable

UCSF scientist says Biden’s cancer moonshot achievable

OAKLAND, Calif. - President Biden revived his call for a nationwide cancer moonshot effort on Monday, as he marked the 60th anniversary of President…

Read More